The recent run-up in stocks, an expected economic expansion, and hopes of recovery in consumer demand have kept analysts busy as they continue …
Shares of GenMark Diagnostics rose 6.6% in Tuesday’s pre-market trading as the company announced an 84% year-over-year jump in its preliminary fourth-quarter revenue …
GenMark Diagnostics shares jumped 12.6% in the after-market trading hours on Thursday as the company announced strong preliminary results for the third quarter.
Shares in GenMark Diagnostics (GNMK) are soaring 10% in Wednesday’s pre-market trading after the molecular diagnostics company announced impressive preliminary financial and operational …
After the close on Tuesday, GenMark (GNMK) preannounced above-consensus 1Q20 revenue given tailwinds from COVID-19 testing. The molecular diagnostics company is now expecting …
In the battle against the coronavirus, who will be able to defeat this formidable foe? In the three months since the onset of this public health crisis, names from …
Analysts are weighing in on medical test maker GenMark Diagnostics, Inc (NASDAQ:GNMK) and biotech firm PTC Therapeutics, Inc. (NASDAQ:PTCT), as both stocks hit their 52-week …
